Table 7.
The rates of occurrence of acute SI phases, and registration of lethal outcomes in the comparison groups (%).
| Group | RL, % | LO, % | Phases of SI (100%—All SI Cases) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | Development/Interphase Transition/Permission | Phlogogenic Stroke 1 | Depressive | ||
| Control 1 (donors), n = 50 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Physiological labor, n = 12 | 50 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Septic shock, n = 14 | 0 | 0 | 7.1 | 14.3 | 42.9 | 35.7 3 | 71.4 3 | 0 | 78.6 1 | 21.4 3 |
| Septic shock tertiary sepsis, n = 17 | 0.00 | 0 | 35.29 | 58.82 | 5.88 | 0.00 3 | 94.1 3 | 0 | 5.9 2 | 94.1 3 |
Note. SI—systemic inflammation; RL—reactivity level; LO—lethal outcomes. 1—primary phlogogenic stroke phase (cytokine storm) was determined on the 1st–2nd days of observation; secondary phlogogenic stroke, on the 5th–7th days and thereafter; 2—secondary phlogogenic stroke phase. 3—statistically significant differences between acute and prolonged variants of septic shock in LO rates, phase relation, and RL range (Chi-square test, p < 0.001). More similar data for both SS groups were presented in another article of ours [13].